Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oral vernakalant: Phase IIb ongoing

COM said interim data from an ongoing double-blind, placebo-controlled Phase IIb trial of oral

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE